Summary
Incubation of slices of rat renal cortex with 50 μM L-DOPA during 15 min resulted in the formation of dopamine and of its deaminated (3,4-dihydroxyphenylacetic acid; DOPAC), methylated (3-methoxytyramine; 3-MT) and deaminated plus methylated (homovanillic acid; HVA) metabolites. The presence of pargyline (100 μM) resulted in a 90% reduction in the formation of DOPAC and HVA; levels of dopamine and 3-MT were found to be significantly increased. A concentration dependent decrease in the formation of methylated metabolites was obtained in the presence of (10, 50 and 100 μM) tropolone (10–50% reduction) and (0.1, 0.5, 1.0 and 5.0 μM) RO 40-7592 (50–95% reduction). Ro 40-7592 was also found to significantly increase DOPAC (20–40%) and dopamine (10–30%) levels, whereas tropolone slightly increased DOPAC (10%) levels. These results show that deamination represents the major pathway in the metabolism of newly formed dopamine under in vitro experimental conditions in the rat kidney. In addition, only when MAO is inhibited does methylation appear to represent an alternative metabolic pathway.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baines AD, Chan W (1980) Production of urine free dopamine from dopa: a micro-puncture study. Life Sci 26: 253–259.
Caramona MM, Soares-da-Silva P (1990) Evidence for an extraneuronal location of monoamine oxidase in renal tissues. Naunyn Schmiedebergs Arch Pharmacol 341: 411–413.
Fernandes MH, Soares-da-Silva P (1990) Effects of MAO-A and MAO-B selective inhibitors Ro 41-1049 and Ro 19-6327 on the deamination of newly-formed dopamine in the rat kidney. J Pharmacol Exp Ther 255: 1309–1313.
Fernandes MH, Pestana M, Soares-da-Silva P (1991) Deamination of newly-formed dopamine in rat renal tissues. Br J Pharmacol 102: 778–782.
Fernandes MH, Soares-da-Silva P (1992) Type A and B monoamine oxidase activities in the human and rat kidney. Acta Physiol Scand 145: 363–367.
Kopin IJ (1985) Catecholamine metabolism: basic aspects and clinical significance. Pharmacol Rev 37: 333–364.
Siragy HM, Felder RA, Howell NL, Chevalier RL, Peach MJ, Carey RM (1989) Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol 257: F469–F477.
Soares-da-Silva P, Garrett MC (1990) A kinetic study of the rate of formation of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) in the rat brain: implications for the origin of DOPAC. Neuropharmacology 29: 869–874.
Zurcher G, Keller HH, Getier R, Borgulya J, Bonetti EP, Eigenmann R, Da Prada M (1990) Ro 40-7592, a novel, very potent, and orally active inhibitor of caytechol-O-methyltransferase: a pharmacological study in rats. Adv Neurol 53: 497–503.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag
About this paper
Cite this paper
Fernandes, M.H., Soares-da-Silva, P. (1994). Role of monoamine oxidase and cathecol-O-methyltransferase in the metabolism of renal dopamine. In: Tipton, K.F., Youdim, M.B.H., Barwell, C.J., Callingham, B.A., Lyles, G.A. (eds) Amine Oxidases: Function and Dysfunction. Journal of Neural Transmission, vol 41. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9324-2_13
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9324-2_13
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82521-1
Online ISBN: 978-3-7091-9324-2
eBook Packages: Springer Book Archive